Such-Lupe

STADA securities

STADA Arzneimittel AG

Bad Vilbel

Official notice
to holders of warrants
issued by our company
(SIN 725 184 // ISIN DE0007251845)
and
to holders of bearer bonds with warrants attached
(SIN 106 954 // ISIN DE0001069540)

(This is a non-binding translation of the original German version.)

Following the decision by STADA Arzneimittel AG on September 22, 2003 to launch a rights issue granting pre-emption rights to existing shareholders, the terms and conditions governing the company's warrants are to be amended as follows for the above securities pursuant to § 7 (1) a of the terms and conditions governing warrants with effect from October 14, 2003:

The strike price - adjusted to EUR 30.00 with effect from October 2, 2000 in the official notice of September 2000 (§ 1 (2) sentence 2 of the terms and conditions governing warrants) - now amounts to EUR 27.90. The premium payable for a warrant entitling the holder to subscribe for 10 shares of STADA Arzneimittel Aktiengesellschaft (§ 1 (2) sentence 1 of the terms and conditions governing warrants) now amounts to EUR 329.00 instead of EUR 350.00. The reduced premium payable for a warrant entitling the holder to subscribe for 10 shares of STADA Arzneimittel AG (§ 1 (2) sentence 2 of the terms and conditions governing warrants) amounts to EUR 279.00. The other terms and conditions remain unchanged.

Bad Vilbel, October 2003

STADA Arzneimittel AG

The Executive Board

Here we have provided you with an overview of important facts and information from strategy through business segments, sales networks and the history of STADA Arzneimittel AG. More
The management of STADA Arzneimittel AG introduce themselves! Here you will find the members of the Executive Board, the Supervisory Board and the Advisory Board. More
Here you will find corporate news and ad-hoc releases that you can read directly on your screen or download as a PDF file. Older releases are available for you in our archive. More
Notices in accordance with the German Securities Trading Act (WpHG) as well as the annual document and the annual financial statements of STADA Arzneimittel AG can be viewed here. More

 

(c) 2012 STADA Arzneimittel AG, Stadastraße 2-18, 61118 Bad Vilbel, Telefon 06101 603-0, Fax 06101 603-259, e-Mail: info@stada.de